Companies Dominating the Fibromyalgia Treatment Landscape
- Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- AbbVie Inc.
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline plc
- Aptinyx Inc.
- Tonix Pharmaceuticals Holding Corp.
- Virios Therapeutics
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Fibromyalgia Treatment Market in 2025 is evaluated at USD 243.97 million.
The global market size was worth around USD 226.91 million in 2024 and is set to register a CAGR of more than 9.4%, exceeding USD 729.59 million revenue by 2037.
North America is likely to surpass majority share by 2037, fueled by increasing prevalence and awareness of fibromyalgia.
The major players in the market include Pfizer Inc., AbbVie Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Aptinyx Inc., Tonix Pharmaceuticals Holding Corp., Virios Therapeutics.
